Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 407

1.

Attitudes and Knowledge Regarding Postmortem Cornea Donation among Young and Elderly People in Germany: Sufficient for Decision Making?

Mihailovic N, Bartel CC, Rosenberger F, Brücher VC, Eter N, Beyer T, Schmidt H, Uhlig CE.

Ophthalmic Res. 2019;62(3):173-184. doi: 10.1159/000501642. Epub 2019 Aug 14.

PMID:
31412333
2.

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, Berzaczy D, Raderer M, Preusser M, Hochmair M, Kiesewetter B, Scheuba C, Ba-Ssalamah A, Karanikas G, Kesselbacher J, Prager G, Dieckmann K, Polterauer S, Weber M, Rausch I, Brauner B, Eidherr H, Wadsak W, Haug AR.

Eur J Nucl Med Mol Imaging. 2019 Aug 13. doi: 10.1007/s00259-019-04452-y. [Epub ahead of print]

PMID:
31410538
3.

The promise of fully-integrated PET/MR imaging: Non-invasive clinical quantification of cerebral glucose metabolism.

Shiyam Sundar LK, Muzik O, Rischka L, Hahn A, Lanzenberger R, Hienert M, Klebermass EM, Bauer M, Rausch I, Pataraia E, Traub-Weidinger T, Beyer T.

J Nucl Med. 2019 Aug 2. pii: jnumed.119.229567. doi: 10.2967/jnumed.119.229567. [Epub ahead of print]

PMID:
31375567
4.

Design, Implementation, and Evaluation of a Head and Neck MRI RF Array Integrated with a 511 keV Transmission Source for Attenuation Correction in PET/MR.

Navarro de Lara LI, Frass-Kriegl R, Renner A, Sieg J, Pichler M, Bogner T, Moser E, Beyer T, Birkfellner W, Figl M, Laistler E.

Sensors (Basel). 2019 Jul 26;19(15). pii: E3297. doi: 10.3390/s19153297.

5.

Gaining Insights into the Function of Post-Translational Protein Modification Using Genome Engineering and Molecular Cell Biology.

Schmidhauser M, Renz PF, Tsikrika P, Freimann R, Wutz A, Wrana JL, Beyer TA.

J Mol Biol. 2019 Sep 6;431(19):3920-3932. doi: 10.1016/j.jmb.2019.07.015. Epub 2019 Jul 12.

PMID:
31306665
6.

Correction to: European multicentre study on technical success and long-term clinical outcome of radiofrequency ablation for the treatment of spinal osteoid osteomas and osteoblastomas.

Beyer T, van Rijswijk CSP, Villagrán JM, Rehnitz C, Muto M, von Falck C, Gielen J, Thierfelder KM, Weber MA.

Neuroradiology. 2019 Aug;61(8):943. doi: 10.1007/s00234-019-02246-5.

PMID:
31214733
7.

European multicentre study on technical success and long-term clinical outcome of radiofrequency ablation for the treatment of spinal osteoid osteomas and osteoblastomas.

Beyer T, van Rijswijk CSP, Villagrán JM, Rehnitz C, Muto M, von Falck C, Gielen J, Thierfelder KM, Weber MA.

Neuroradiology. 2019 Aug;61(8):935-942. doi: 10.1007/s00234-019-02226-9. Epub 2019 Jun 3. Erratum in: Neuroradiology. 2019 Jun 19;:.

PMID:
31161261
8.

Preparing data for multiparametric PET/MR imaging: Influence of PET point spread function modelling and EPI distortion correction on the spatial correlation of [18F]FDG-PET and diffusion-weighted MRI in head and neck cancer.

Olin A, Krogager L, Rasmussen JH, Andersen FL, Specht L, Beyer T, Kjaer A, Fischer BM, Hansen AE.

Phys Med. 2019 May;61:1-7. doi: 10.1016/j.ejmp.2019.04.006. Epub 2019 Apr 17.

9.

State of affairs of hybrid imaging in Europe: two multi-national surveys from 2017.

Gatidis S, Beyer T, Becker M, Riklund K, Nikolaou K, Cyran C, Pfannenberg C.

Insights Imaging. 2019 May 21;10(1):57. doi: 10.1186/s13244-019-0741-7.

10.

Impact of intensity discretization on textural indices of [18F]FDG-PET tumour heterogeneity in lung cancer patients.

Forgács A, Béresová M, Garai I, Lassen ML, Beyer T, DiFranco MD, Berényi E, Balkay L.

Phys Med Biol. 2019 Jun 20;64(12):125016. doi: 10.1088/1361-6560/ab2328.

PMID:
31108468
11.

Quantitative PET/MR imaging of lung cancer in the presence of artifacts in the MR-based attenuation correction maps.

Kuttner S, Lassen ML, Øen SK, Sundset R, Beyer T, Eikenes L.

Acta Radiol. 2019 May 15:284185119848118. doi: 10.1177/0284185119848118. [Epub ahead of print]

PMID:
31091969
12.

Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria.

Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KSJ, Gückel B, Jačan A, Haslacher H, Hicks RJ, Kenner L, Langanke M, Mitterhauser M, Pichler BJ, Salih HR, Schibli R, Schulz S, Simecek J, Simon J, Soares MO, Stelzl U, Wadsak W, Zatloukal K, Zeitlinger M, Hacker M.

Mol Imaging Biol. 2019 May 2. doi: 10.1007/s11307-019-01361-2. [Epub ahead of print]

PMID:
31049831
13.

A PARATHYROID ADENOMA IN THE STERNOHYOID MUSCLE.

Usmani M, Beyer TD, Shawa H.

Endocr Pract. 2019 Apr 23. doi: 10.4158/EP-2019-0105. [Epub ahead of print] No abstract available.

PMID:
31013154
14.

Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.

Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K; Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:; Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge:.

Nuklearmedizin. 2019 Mar;58(2):68-76. doi: 10.1055/a-0830-4453. Epub 2019 Feb 28.

PMID:
30818412
15.

Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.

Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K; Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:; Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge:.

Rofo. 2019 Apr;191(4):289-297. doi: 10.1055/a-0828-8654. Epub 2019 Feb 28.

16.

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

Nakamura K, Saredi G, Becker JR, Foster BM, Nguyen NV, Beyer TE, Cesa LC, Faull PA, Lukauskas S, Frimurer T, Chapman JR, Bartke T, Groth A.

Nat Cell Biol. 2019 Mar;21(3):311-318. doi: 10.1038/s41556-019-0282-9. Epub 2019 Feb 25.

17.

Data-driven, projection-based respiratory motion compensation of PET data for cardiac PET/CT and PET/MR imaging.

Lassen ML, Beyer T, Berger A, Beitzke D, Rasul S, Büther F, Hacker M, Cal-González J.

J Nucl Cardiol. 2019 Feb 13. doi: 10.1007/s12350-019-01613-2. [Epub ahead of print]

PMID:
30761482
18.

Dynamic [18F]FET-PET/MRI using standard MRI-based attenuation correction methods.

Rausch I, Zitterl A, Berroterán-Infante N, Rischka L, Prayer D, Fenchel M, Sareshgi RA, Haug AR, Hacker M, Beyer T, Traub-Weidinger T.

Eur Radiol. 2019 Aug;29(8):4276-4285. doi: 10.1007/s00330-018-5942-9. Epub 2019 Jan 11.

19.

Early luteal phase progestin concentration influences endometrial function in pregnant mares.

Beyer T, Rink BE, Scarlet D, Walter I, Kunert S, Aurich C.

Theriogenology. 2019 Feb;125:236-241. doi: 10.1016/j.theriogenology.2018.11.018. Epub 2018 Nov 19.

PMID:
30476756
20.

Hypertriglyceridemia-Induced Pancreatitis: A Case Series of 56 Patients from One Institution.

Martinolich J, Midura D, Benton M, Ata A, Stain SC, Beyer TD.

Am Surg. 2018 Sep 1;84(9):e388-e390. No abstract available.

PMID:
30454508
21.

An Early Function of Polycystin-2 for Left-Right Organizer Induction in Xenopus.

Vick P, Kreis J, Schneider I, Tingler M, Getwan M, Thumberger T, Beyer T, Schweickert A, Blum M.

iScience. 2018 Apr 27;2:76-85. doi: 10.1016/j.isci.2018.03.011. Epub 2018 Apr 7.

22.

A head coil system with an integrated orbiting transmission point source mechanism for attenuation correction in PET/MRI.

Renner A, Rausch I, Cal Gonzalez J, Frass-Kriegl R, de Lara LN, Sieg J, Laistler E, Glanzer M, Dungl D, Moser E, Beyer T, Figl M, Birkfellner W.

Phys Med Biol. 2018 Nov 12;63(22):225014. doi: 10.1088/1361-6560/aae9a9.

PMID:
30418935
23.

In Patients We Trust: Reliability of Self-Reported Weight and Height in Nuclear Medicine Patients.

Blum KS, Büsch N, Beyer T, Rausch I, Freudenberg LS.

J Nucl Med Technol. 2019 Jun;47(2):133-136. doi: 10.2967/jnmt.118.216317. Epub 2018 Nov 9.

PMID:
30413597
24.

Optimized Feature Extraction for Radiomics Analysis of 18F-FDG PET Imaging.

Papp L, Rausch I, Grahovac M, Hacker M, Beyer T.

J Nucl Med. 2019 Jun;60(6):864-872. doi: 10.2967/jnumed.118.217612. Epub 2018 Nov 2.

PMID:
30389820
25.

An International Survey on Clinical Reporting of PET/CT Examinations: A Starting Point for Cross-Specialty Engagement.

Freudenberg LS, Hicks RJ, Beyer T.

J Nucl Med. 2019 Apr;60(4):480-485. doi: 10.2967/jnumed.118.218073. Epub 2018 Nov 2.

PMID:
30389815
26.

Performance Evaluation of the Vereos PET/CT System According to the NEMA NU2-2012 Standard.

Rausch I, Ruiz A, Valverde-Pascual I, Cal-González J, Beyer T, Carrio I.

J Nucl Med. 2019 Apr;60(4):561-567. doi: 10.2967/jnumed.118.215541. Epub 2018 Oct 25.

PMID:
30361382
27.

A new model for training in hybrid imaging.

Hicks RJ, Freudenberg L, Beyer T.

Lancet Oncol. 2018 Sep;19(9):1152-1154. doi: 10.1016/S1470-2045(18)30482-0. No abstract available.

PMID:
30191837
28.

Towards quantitative [18F]FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates.

Sundar LK, Muzik O, Rischka L, Hahn A, Rausch I, Lanzenberger R, Hienert M, Klebermass EM, Füchsel FG, Hacker M, Pilz M, Pataraia E, Traub-Weidinger T, Beyer T.

J Cereb Blood Flow Metab. 2019 Aug;39(8):1516-1530. doi: 10.1177/0271678X18776820. Epub 2018 May 23.

29.

The Fate of Autologous Endometrial Mesenchymal Stromal Cells After Application in the Healthy Equine Uterus.

Rink BE, Beyer T, French HM, Watson E, Aurich C, Donadeu FX.

Stem Cells Dev. 2018 Aug 1;27(15):1046-1052. doi: 10.1089/scd.2018.0056. Epub 2018 Jun 29.

30.

An international survey on hybrid imaging: do technology advances preempt our training and education efforts?

Beyer T, Hicks R, Brun C, Antoch G, Freudenberg LS.

Cancer Imaging. 2018 Apr 26;18(1):15. doi: 10.1186/s40644-018-0148-6.

31.

CRISPR/Cas9-mediated Genomic Editing of Cluap1/IFT38 Reveals a New Role in Actin Arrangement.

Beyer T, Bolz S, Junger K, Horn N, Moniruzzaman M, Wissinger Y, Ueffing M, Boldt K.

Mol Cell Proteomics. 2018 Jul;17(7):1285-1294. doi: 10.1074/mcp.RA117.000487. Epub 2018 Apr 3.

32.

Life is not black and white, nor just Shades of Gray.

Beyer T, Hicks RJ, Freudenberg LS.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):816-821. doi: 10.1007/s00259-018-3943-1. Epub 2018 Feb 8. No abstract available.

PMID:
29423530
33.

Impact of motion compensation and partial volume correction for 18F-NaF PET/CT imaging of coronary plaque.

Cal-González J, Tsoumpas C, Lassen ML, Rasul S, Koller L, Hacker M, Schäfers K, Beyer T.

Phys Med Biol. 2017 Dec 14;63(1):015005. doi: 10.1088/1361-6560/aa97c8.

34.

Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning.

Papp L, Pötsch N, Grahovac M, Schmidbauer V, Woehrer A, Preusser M, Mitterhauser M, Kiesel B, Wadsak W, Beyer T, Hacker M, Traub-Weidinger T.

J Nucl Med. 2018 Jun;59(6):892-899. doi: 10.2967/jnumed.117.202267. Epub 2017 Nov 24.

35.

Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI.

Lassen ML, Rasul S, Beitzke D, Stelzmüller ME, Cal-Gonzalez J, Hacker M, Beyer T.

J Nucl Cardiol. 2019 Aug;26(4):1107-1118. doi: 10.1007/s12350-017-1118-2. Epub 2017 Nov 22.

36.

Impact of motion compensation and partial volume correction for <sup>18</sup>F-NaF PET/CT imaging of coronary plaque.

Cal-Gonzalez J, Tsoumpas CH, Lassen ML, Rasul S, Koller L, Hacker M, Schäfers KP, Beyer T.

Phys Med Biol. 2017 Nov 2. doi: 10.1088/1361-6560/aa97c8. [Epub ahead of print]

PMID:
29095701
37.

Comparative analysis of differential gene expression tools for RNA sequencing time course data.

Spies D, Renz PF, Beyer TA, Ciaudo C.

Brief Bioinform. 2019 Jan 18;20(1):288-298. doi: 10.1093/bib/bbx115.

38.

Quantification accuracy of neuro-oncology PET data as a function of emission scan duration in PET/MR compared to PET/CT.

Wampl S, Rausch I, Traub-Weidinger T, Beyer T, Gröschl M, Cal-González J.

Eur J Radiol. 2017 Oct;95:257-264. doi: 10.1016/j.ejrad.2017.08.024. Epub 2017 Aug 26.

PMID:
28987677
39.

Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.

Bailey DL, Pichler BJ, Gückel B, Antoch G, Barthel H, Bhujwalla ZM, Biskup S, Biswal S, Bitzer M, Boellaard R, Braren RF, Brendle C, Brindle K, Chiti A, la Fougère C, Gillies R, Goh V, Goyen M, Hacker M, Heukamp L, Knudsen GM, Krackhardt AM, Law I, Morris JC, Nikolaou K, Nuyts J, Ordonez AA, Pantel K, Quick HH, Riklund K, Sabri O, Sattler B, Troost EGC, Zaiss M, Zender L, Beyer T.

Mol Imaging Biol. 2018 Feb;20(1):4-20. doi: 10.1007/s11307-017-1123-5.

40.

TRAF6: A player in CVB3-induced myocarditis?

Ursu ON, Beyer T, Sauter M, Fragasso A, Bundschuh S, Klingel K, Munz B.

Cytokine. 2019 Oct;122:154143. doi: 10.1016/j.cyto.2017.08.023. Epub 2017 Sep 6.

PMID:
28886971
41.

Saving costs in cancer patient management through molecular imaging.

von Gall C, Maniawski P, Verzijlbergen F, Carrio I, Beyer T, Kalemis A.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2153-2157. doi: 10.1007/s00259-017-3804-3. Epub 2017 Aug 14. No abstract available.

42.

Reproducibility of Quantitative Brain Imaging Using a PET-Only and a Combined PET/MR System.

Lassen ML, Muzik O, Beyer T, Hacker M, Ladefoged CN, Cal-González J, Wadsak W, Rausch I, Langer O, Bauer M.

Front Neurosci. 2017 Jul 17;11:396. doi: 10.3389/fnins.2017.00396. eCollection 2017.

43.

PET/MRI-knocking on the doors of the rich and famous.

Beyer T, Hacker M, Goh V.

Br J Radiol. 2017 Aug;90(1077):20170347. doi: 10.1259/bjr.20170347. Epub 2017 Jul 27. Review.

44.

Technical and instrumentational foundations of PET/MRI.

Rausch I, Quick HH, Cal-Gonzalez J, Sattler B, Boellaard R, Beyer T.

Eur J Radiol. 2017 Sep;94:A3-A13. doi: 10.1016/j.ejrad.2017.04.004. Epub 2017 Apr 8. Review.

PMID:
28431784
45.

Molecular Mechanisms of Stem Cell Pluripotency and Cell Fate Specification.

Findlay GM, David L, Beyer TA.

J Mol Biol. 2017 May 19;429(10):1439-1440. doi: 10.1016/j.jmb.2017.03.011. Epub 2017 Mar 14. No abstract available.

PMID:
28302388
46.

PET/MRI for Oncologic Brain Imaging: A Comparison of Standard MR-Based Attenuation Corrections with a Model-Based Approach for the Siemens mMR PET/MR System.

Rausch I, Rischka L, Ladefoged CN, Furtner J, Fenchel M, Hahn A, Lanzenberger R, Mayerhoefer ME, Traub-Weidinger T, Beyer T.

J Nucl Med. 2017 Sep;58(9):1519-1525. doi: 10.2967/jnumed.116.186148. Epub 2017 Mar 2.

47.

Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by 18F-Fluoride and 18F-FDG.

Li X, Heber D, Cal-Gonzalez J, Karanikas G, Mayerhoefer ME, Rasul S, Beitzke D, Zhang X, Agis H, Mitterhauser M, Wadsak W, Beyer T, Loewe C, Hacker M.

J Nucl Med. 2017 Jun;58(6):968-974. doi: 10.2967/jnumed.116.182790. Epub 2017 Feb 23.

48.

Technical Note: Fully-automated analysis of Jaszczak phantom measurements as part of routine SPECT quality control.

Hirtl A, Bergmann H, Knäusl B, Beyer T, Figl M, Hummel J.

Med Phys. 2017 May;44(5):1638-1645. doi: 10.1002/mp.12150. Epub 2017 Apr 12.

PMID:
28186647
49.

Partial volume correction for improved PET quantification in 18F-NaF imaging of atherosclerotic plaques.

Cal-Gonzalez J, Li X, Heber D, Rausch I, Moore SC, Schäfers K, Hacker M, Beyer T.

J Nucl Cardiol. 2018 Oct;25(5):1742-1756. doi: 10.1007/s12350-017-0778-2. Epub 2017 Feb 7.

50.

Quantitative characterization of the mechanism of action and impact of a 'proteolysis-permitting' anti-PCSK9 antibody.

Hansen RJ, Berna MJ, Sperry AE, Beyer TP, Wroblewski VJ, Schroeder KM, Eacho PI.

MAbs. 2017 Feb/Mar;9(2):285-296. doi: 10.1080/19420862.2016.1270490.

Supplemental Content

Support Center